Allarity Therapeutics (ALLR) Current Assets (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Current Assets came in at $34.5 million in Q1 2026, up 17.27% YoY from $29.4 million in Q1 2025, and up 92.45% on a QoQ basis from $17.9 million in Q4 2025.
Allarity Therapeutics (ALLR) Current Assets (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Current Assets data on file, last reported at $34.5 million in Q1 2026.
- Quarterly Current Assets rose 17.27% year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.5 million (up 17.27% YoY) and the FY2025 annual result came in at $17.9 million, down 19.75% from the prior year.
- Current Assets climbed to $34.5 million in Q1 2026, from $17.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $34.5 million in Q1 2026 to a low of $2.0 million in Q4 2023.
- A 5-year average of $14.2 million and a median of $17.2 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slumped 82.77% — and 2025, when it soared 1182.0%.
- Tracing ALLR's Current Assets over 5 years: stood at $5.0 million in 2022, then tumbled by 60.33% to $2.0 million in 2023, then surged by 1033.49% to $22.3 million in 2024, then retreated by 19.75% to $17.9 million in 2025, then jumped by 92.45% to $34.5 million in 2026.
- The last three Current Assets figures came in at $34.5 million (Q1 2026), $17.9 million (Q4 2025), and $20.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 1.76 Bn |
| 10 | Allarity Therapeutics | 22.39 Mn | 22.39 Mn | - | 31.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.50 Mn |
| Dec 31, 2025 | 17.93 Mn |
| Sep 30, 2025 | 20.47 Mn |
| Jun 30, 2025 | 20.88 Mn |
| Mar 31, 2025 | 29.42 Mn |
| Dec 31, 2024 | 22.34 Mn |
| Sep 30, 2024 | 20.37 Mn |
| Jun 30, 2024 | 21.31 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 2.97 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 6.06 Mn |
| Jun 30, 2022 | 10.12 Mn |
| Mar 31, 2022 | 17.21 Mn |
| Dec 31, 2021 | 21.40 Mn |
| Sep 30, 2021 | 7.64 Mn |
| Dec 31, 2020 | 1.72 Mn |